Clinical trial
Antidepressant Prophylaxis for Interferon-Induced Depression: Efficacy of…
NCT00357045 · Portland VA Medical Center, U.S. Fed · Completed
Key facts
| NCT number | NCT00357045 |
|---|---|
| Title | Antidepressant Prophylaxis for Interferon-Induced Depression: Efficacy of Paroxetine |
| Official title | Antidepressant Prophylaxis for Interferon-Induced Depression: Efficacy of Paroxetine; THE HEPDEP II STUDY |
| Lead sponsor | Portland VA Medical Center, U.S. Fed |
| Collaborators | GlaxoSmithKline Industry Schering-Plough |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Major Depression |
| Intervention type | Drug |
| Interventions | Paroxetine |
| First posted | Jul 27, 2006 |
| Last update posted | Jul 27, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: